United States

Everybody and his uncle, it seems, has an idea of something that might work to cure people infected with the deadly virus

 SCIENTIFIC AMERICAN    By Helen Branswell                        Dec. 4, 2014

When it comes to treatments for Ebola, there has been a nearly four-decade-long drought. Nothing in the medical arsenal attacks the virus directly....

Dr. John M. Dye, Jr., U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) Viral Immunology branch chief, works in a laboratory at the USAMRIID headquarters in Frederick, Maryland. Dr. Dye is leading a team that is conducting a study with nonhuman primates involving the experimental drug ZMapp, an experimental treatment for Ebola patients. Credit: CDC

BLOOMBERG--By Andrew Pollack and Doni Bloomfield                                                                  Dec.4, 2014

ATLANTA-- An American health worker who may have been exposed to the Ebola virus arrived at an Atlanta hospital today for possible treatment after being evacuated by air from West Africa, where the outbreak is at its worst.

The health worker, who hasn’t been publicly identified, was admitted this morning at Emory University Hospital, which has successfully treated four other Ebola patients, the hospital said in an e-mail.

“Emory cannot share more details out of respect for patient privacy and in accordance with the patient’s wishes,” the hospital said. Phoenix Air, a medical charter company, flew the patient from West Africa, according to the statement. Earlier this week, Emory was named one of 35 U.S. hospitals designated to treat Ebola patients.

Emory didn’t say in what country the health worker may have been exposed.
Read complete story.

http://www.bloomberg.com/news/2014-12-04/health-care-worker-who-may-have-ebola-headed-to-u-s-.html

100resilientcities.org - by Michael Berkowitz - December 2, 2014

Today we proudly announce the second group of cities selected to join 100 Resilient Cities – cities who have demonstrated a commitment to building their own capacities to navigate the shocks and stresses of an increasingly complex 21st Century.

During the our first 18 months, we've seen our first cohort of cities mature, appoint chief resilience officers, and embark on their own resilience strategy processes. No doubt this momentum contributed to the immense response we saw to the second round of the 100 Resilient Cities Challenge has been enormous, with 331 exceptional applications from cities around the world, submitted in seven languages.

With trials under way, scientists are working out how to give vaccines in affected regions

NATURE   By Ewan Callaway                                                                                                 Dec. 2, 2014

Safety trials of Ebola vaccines are starting to return results: at least one is known to be safe and to summon an immune response against the virus.

The challenge now is to use the results to guide the larger studies that will reveal whether the vaccines work.

“The immune responses are there,” says infectious-disease researcher Adrian Hill, director of the Jenner Institute in Oxford, UK. “The tough call is whether they’re enough to protect humans against Ebola.”

Read complete story

http://www.nature.com/news/positive-results-spur-race-for-ebola-vaccine-1.16468